Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 10, 2023 11:32 AM 2 min read

Supreme Court Settlement Paves Way For New York Medical Marijuana Shops To Enter Adult Market On Dec. 29

by Maureen Meehan Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo

Following a months-long legal standoff that had New York cannabis shop owners in a holding pattern and state regulators unable to hand out new business licenses, the doors are finally opening.

With last week’s lifting of a NY Supreme Court injunction, which had been in place since August after a group of veterans sued over the state’s licensing process, the Cannabis Control Board (CCB) gave the green light to six of 10 licensed medical marijuana companies operating in New York to begin selling recreational weed on Dec. 29, one year to the day after adult-use sales launched in New York in 2022.

The six medical marijuana companies, some of which are multi-state operators (MSO), that were given permission to sell adult-use cannabis include: 

Tremaine Wright, chairperson of the CCB, stressed the importance of putting the litigation in the rearview mirror and moving New York’s cannabis industry forward.

“It was an unnecessary delay in the progress of cannabis in New York state. We are so thankful that it now has ended and we have come to a settlement,” Wright said per Spectrum News. “There is room for everyone, for all business types and we have a multitude of licensing opportunities.” 

“We expect New York to be the hub, or one of the hubs, for legal cannabis on the East Coast,” said Curaleaf CEO Matt Darin in October. “And so we’re very bullish and we’ve invested a lot of capital and time to be able to maximize the opportunity.”

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
CannabisGovernmentNewsRegulationsRetail SalesMarkets
CRLBF Logo
CRLBFCresco Labs Inc
$1.2014.3%
Overview
CURLF Logo
CURLFCuraleaf Holdings Inc
$2.27-4.22%
GTBIF Logo
GTBIFGreen Thumb Industries Inc
$6.675.21%
ITHUF Logo
ITHUFiAnthus Capital Holdings Inc
$0.00410-%

Columbia Care (OTCQX: CCHWF); Curaleaf NY LLC (OTCQX: CURLF); Etain LLC, which is owned by Riv Capital (OTCPK: CNPOF); NYCANNA LLC, which is owned by Acreage Holdings Inc. (OTCQX: ACRHF), PharmaCann of New York LLC and Valley Agriceuticals LLC, which is owned by Cresco Labs (OTCQX: CRLBF), according to the Green Market Report. 

GMR also noted that the six companies were permitted to set up co-located recreational sales at up to three of their existing medical marijuana (MMJ) shops, though, at the moment, they're only approved for a single shop that can open on Dec. 29. Four other New York MMJ companies that were not mentioned during the CCB meeting, wrote the outlet, are eligible to apply for transition into New York’s potentially billion-dollar recreational weed market, include Citiva Medical LLC, which is owned by iAnthus Capital Holdings Inc. (OTCQB: ITHUF), Fiorello Pharmaceuticals, owned by Green Thumb Industries (OTCQX: GTBIF),  MedMen (OTCQX: MMNFF), Vireo Health International, which does business as Goodness Growth Holdings (CSE:GDNS) (OTCQX: GDNSF).

CRLBF Logo
CRLBFCresco Labs Inc
$1.2014.3%
Overview
CURLF Logo
CURLFCuraleaf Holdings Inc
$2.27-4.22%
GTBIF Logo
GTBIFGreen Thumb Industries Inc
$6.675.21%
ITHUF Logo
ITHUFiAnthus Capital Holdings Inc
$0.00410-%
Comments
Loading...